- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Environmental and Public Health
Volume 2012 (2012), Article ID 481641, 5 pages
Urinary Bisphenol A and Hypertension in a Multiethnic Sample of US Adults
Department of Community Medicine, West Virginia University School of Medicine, P.O. Box 9190, Morgantown, WV 26506-9190, USA
Received 28 June 2011; Accepted 2 December 2011
Academic Editor: Michael Bates
Copyright © 2012 Anoop Shankar and Srinivas Teppala. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- L. N. Vandenberg, M. V. Maffini, C. Sonnenschein, B. S. Rubin, and A. M. Soto, “Bisphenol-a and the great divide: a review of controversies in the field of endocrine disruption,” Endocrine Reviews, vol. 30, no. 1, pp. 75–95, 2009.
- A. M. Calafat, Z. Kuklenyik, J. A. Reidy, S. P. Caudill, J. Ekong, and L. L. Needham, “Urinary concentrations of bisphenol A and 4-Nonylphenol in a human reference population,” Environmental Health Perspectives, vol. 113, no. 4, pp. 391–395, 2005.
- A. M. Calafat, X. Ye, L. Y. Wong, J. A. Reidy, and L. L. Needham, “Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004,” Environmental Health Perspectives, vol. 116, no. 1, pp. 39–44, 2008.
- K. Moriyama, T. Tagami, T. Akamizu et al., “Thyroid hormone action is disrupted by bisphenol A as an antagonist,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 11, pp. 5185–5190, 2002.
- B. S. Rubin and A. M. Soto, “Bisphenol A: perinatal exposure and body weight,” Molecular and Cellular Endocrinology, vol. 304, no. 1-2, pp. 55–62, 2009.
- R. R. Newbold, E. Padilla-Banks, and W. N. Jefferson, “Environmental estrogens and obesity,” Molecular and Cellular Endocrinology, vol. 304, no. 1-2, pp. 84–89, 2009.
- A. Shankar and S. Teppala, “Relationship between urinary bisphenol A levels and diabetes mellitus,” Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 12, pp. 3822–3826, 2011.
- I. A. Lang, T. S. Galloway, A. Scarlett et al., “Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults,” Journal of the American Medical Association, vol. 300, no. 11, pp. 1303–1310, 2008.
- D. Melzer, N. E. Rice, C. Lewis, W. E. Henley, and T. S. Galloway, “Association of urinary bisphenol A concentration with heart disease: evidence from NHANES 2003–06,” PLoS ONE, vol. 5, no. 1, Article ID e8673, 2010.
- J. Miyawaki, K. Sakayama, H. Kato, H. Yamamoto, and H. Masuno, “Perinatal and postnatal exposure to bisphenol A increase adipose tissue mass and serum cholesterol level in mice,” Journal of Atherosclerosis and Thrombosis, vol. 14, no. 5, pp. 245–252, 2007.
- Y. J. Yang, Y. C. Hong, S. Y. Oh et al., “Bisphenol A exposure is associated with oxidative stress and inflammation in postmenopausal women,” Environmental Research, vol. 109, no. 6, pp. 797–801, 2009.
- A. V. Chobanian, G. L. Bakris, H. R. Black et al., “Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure,” Hypertension, vol. 42, no. 6, pp. 1206–1252, 2003.
- D. H. P. Streeten, G. H. Anderson Jr, T. Howland, R. Chiang, and H. Smulyan, “Effects of thyroid function on blood pressure. Recognition of hypothyroid hypertension,” Hypertension, vol. 11, no. 1, pp. 78–83, 1988.
- Juhaeri, J. Stevens, L. E. Chambless et al., “Associations between weight gain and incident hypertension in a bi-ethnic cohort: the atherosclerosis risk in communities study,” International Journal of Obesity, vol. 26, no. 1, pp. 58–64, 2002.
- J. R. Sowers, “Insulin resistance and hypertension,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 286, no. 5, pp. H1597–H1602, 2004.
- D. E. Laaksonen, L. Niskanen, K. Nyyssönen, T. A. Lakka, J. A. Laukkanen, and J. T. Salonen, “Dyslipidaemia as a predictor of hypertension in middle-aged men,” European Heart Journal, vol. 29, no. 20, pp. 2561–2568, 2008.
- R. Rodrigo, H. Prat, W. Passalacqua, J. Araya, C. Guichard, and J. P. Bächler, “Relationship between oxidative stress and essential hypertension,” Hypertension Research, vol. 30, no. 12, pp. 1159–1167, 2007.
- S. G. Lakoski, D. M. Herrington, D. M. Siscovick, and S. B. Hulley, “C-reactive protein concentration and incident hypertension in young adults: the CARDIA study,” Archives of Internal Medicine, vol. 166, no. 3, pp. 345–349, 2006.
- National Center for Health Statistics, “2003-2004 National Health and Nutrition Examination Survey: survey operations manual,” 2010, http://www.cdc.gov/nchs/nhanes/nhanes2003-2004/current_nhanes_03_04.htm.
- American Diabetes Association, “Diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 34, supplement 1, pp. S62–S69, 2011.
- X. Ye, Z. Kuklenyik, L. L. Needham, and A. M. Calafat, “Automated on-line column-switching HPLC-MS/MS method with peak focusing for the determination of nine environmental phenols in urine,” Analytical Chemistry, vol. 77, no. 16, pp. 5407–5413, 2005.
- National Center for Health Statistics, “2003-2004 National Health and Nutrition Examination Survey: Laboratory procedures,” 2010, http://www.cdc.gov/nchs/nhanes/nhanes2003-2004/LEXAB_C.htm.
- P. Phrakonkham, S. Viengchareun, C. Belloir, M. Lombes, Y. Artur, and M. C. Canivenc-Lavier, “Dietary xenoestrogens differentially impair 3T3-L1 preadipocyte differentiation and persistently affect leptin synthesis,” Journal of Steroid Biochemistry and Molecular Biology, vol. 110, no. 1-2, pp. 95–103, 2008.
- H. Masuno, J. Iwanami, T. Kidani, K. Sakayama, and K. Honda, “Bisphenol A accelerates terminal differentiation of 3T3-L1 cells into adipocytes through the phosphatidylinositol 3-kinase pathway,” Toxicological Sciences, vol. 84, no. 2, pp. 319–327, 2005.
- A. Matsushima, T. Teramoto, H. Okada et al., “ERRγ tethers strongly bisphenol A and 4-α-cumylphenol in an induced-fit manner,” Biochemical and Biophysical Research Communications, vol. 373, no. 3, pp. 408–413, 2008.
- H. M. Wright, C. B. Clish, T. Mikami et al., “A synthetic antagonist for the peroxisome proliferator-activated receptor γ inhibits adipocyte differentiation,” Journal of Biological Chemistry, vol. 275, no. 3, pp. 1873–1877, 2000.
- A. B. Ropero, P. Alonso-Magdalena, E. García-García, C. Ripoll, E. Fuentes, and A. Nadal, “Bisphenol-A disruption of the endocrine pancreas and blood glucose homeostasis,” International Journal of Andrology, vol. 31, no. 2, pp. 194–200, 2008.
- P. Alonso-Magdalena, S. Morimoto, C. Ripoll, E. Fuentes, and A. Nadal, “The estrogenic effect of bisphenol a disrupts pancreatic β-cell function in vivo and induces insulin resistance,” Environmental Health Perspectives, vol. 114, no. 1, pp. 106–112, 2006.
- B. Hennig, B. D. Hammock, R. Slim, M. Toborek, V. Saraswathi, and L. W. Robertson, “PCB-induced oxidative stress in endothelial cells: modulation by nutrients,” International Journal of Hygiene and Environmental Health, vol. 205, no. 1-2, pp. 95–102, 2002.
- J. J. Stegeman, M. E. Hahn, R. Weisbrod et al., “Induction of cytochrome P4501A1 by aryl hydrocarbon receptor agonists in porcine aorta endothelial cells in culture and cytochrome P4501A1 activity in intact cells,” Molecular Pharmacology, vol. 47, no. 2, pp. 296–306, 1995.
- H. Ooe, T. Taira, S. M. M. Iguchi-Ariga, and H. Ariga, “Induction of reactive oxygen species by bisphenol A and abrogation of bisphenol A-induced cell injury by DJ-1,” Toxicological Sciences, vol. 88, no. 1, pp. 114–126, 2005.
- M. R. Lovati, M. Galbussera, G. Franceschini et al., “Increased plasma and aortic triglycerides in rabbits after acute administration of 2,3,7,8-tetrachlorodibenzo-p-dioxin,” Toxicology and Applied Pharmacology, vol. 75, no. 1, pp. 91–97, 1984.
- A. Shankar and J. Li, “Association between serum γ-glutamyltransferase level and prehypertension among US adults,” Circulation Journal, vol. 71, no. 10, pp. 1567–1572, 2007.